Close

Articles

The Value of an Informed Partnership in Launch Management

The drug manufacturing process is complex. It requires a methodical and detail-oriented approach to achieve efficiency and maintain high-quality outcomes, necessary for bringing a drug product to the market. Although every step from pre-clinical to phase III is necessary,...

The Technological Advancement of Injectable Packaging Solutions By Markus Hörburger, Product & Service Manager, Vetter

In the world of pharma and biotech, device assembly and secondary packaging plays a significant role in supporting successful delivery of medicines to patients. As the industry continues to evolve, we are seeing a spike in the variety of...

What’s driving the growth of the biopharma sector across South East Asia?

Standfirst: The healthcare industry, particularly the life-science and biopharma sectors, across ASEAN is seeing a shift away from a reliance on overseas expertise and imported products and technology towards a preference for homegrown solutions. The growth in South East Asia’s...

Prepared for new challenges in cartridge filling

What does an ambitious contract manufacturer need when customers wish to expand their orders? Exactly, new equipment! The Malmö-based Swedish company Rechon has been a reliable partner to many pharmaceutical producers for decades, from clinical trials through to commercial...

Exploring mass spectrometry for RNA and oligonucleotide analysis

The growing interest in genomic research, personalized medicine and ribonucleic acid (RNA)-based therapies is fueling demand for high quality oligonucleotides. RNA is a biological molecule that plays a crucial role in the transfer of genetic information from deoxyribonucleic acid (DNA)...

Logistics innovations are key to fighting the next pandemic

The industry is using lessons learned during, to help eliminate underlying healthcare vulnerabilities and improve speed and efficiency of relief efforts The COVID-19 pandemic is often described as a “once-in-a-century” event. Yet, although the virus arrived almost exactly 100 years...

Preparing for the New Era: A Guide to Transitioning Clinical Trials to CTIS Regulation in the EU

As of January 31, 2022, the EU has implemented the Regulation 2014/536 on clinical trials for Medicinal Products (MPs) intended for human use. This regulation provides a centralized approach for electronic submission and evaluation of clinical trials. Alongside this,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read